Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
QuintilesIMS
Express Scripts
Citi
Merck
Deloitte
Federal Trade Commission
Fuji
Moodys

Generated: August 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles
Abstract:The compound of the formula ##STR1## wherein R.sup.1 is hydrogen, methoxy or trifluoromethyl, R.sup.2 and R.sup.3 are independently hydrogen or methyl, R.sup.4 is a C.sub.2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof is novel, and useful for prophylaxis and therapy of digestive ulcers (e.g. gastric ulcer, duodenal ulcer) and gastritis.
Inventor(s): Nohara; Akira (Kyoto, JP), Maki; Yoshitaka (Kyoto, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:06/937,193
Patent Claims: 1. A phramaceutical composition for preventing or treating digestive ulcers or gastritis, which contains an effective amount of a compound of the formula ##STR8## wherein R.sup.1 is hydrogen, methoxy or trifluoromethyl, R.sup.2 and R.sup.3 are independently hydrogen or methyl, R.sup.4 is a C.sub.2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof, and pharmacologically acceptable carriers.

2. A phamaceutical composition according to claim 1, wherein R.sup.1 is hydrogen or trifluoromethyl.

3. A pharmaceutical composition according to claim 1, wherein R.sup.3 is hydrogen.

4. A pharmaceutical composition according to claim 1, wherein n is 1.

5. A phamaceutical composition according to claim 1, wherein R.sup.1 and R.sup.3 are hydrogen, R.sup.2 is methyl, R.sup.4 is 2,2,2-trifluoroethyl and n is 1.

6. A method for preventing or treating digestive ulcers or gastritis, which comprises administering a compound of the formula ##STR9## wherein R.sup.1 is hydrogen, methoxy or trifluoromethyl, R.sup.2 and R.sup.3 are independently hydrogen or methyl, R.sup.4 is a C.sub.2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof, and pharmacologically acceptable carriers.

7. A method according to claim 6, wherein R.sup.1 is hydrogen or trifluoromethyl.

8. A method according to claim 6, wherein R.sup.3 is hydrogen.

9. A method according to claim 6, wherein n is 1.

10. A method according to claim 6, wherein R.sup.1 and R.sup.3 are hydrogen, R.sup.2 is methyl, R.sup.4 is 2,2,2-trifluoroethyl and n is 1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Merck
Fish and Richardson
Chinese Patent Office
Mallinckrodt
Boehringer Ingelheim
Accenture
Daiichi Sankyo
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot